1. Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J. Primary diffuse large B-cell lymphoma of the breast. A clinicopathologic study of 31 cases. Pathol Res Pract. 1996; 192:37–43.
2. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972; 29:1705–1712.
3. Ferguson DJ. Intraepithelial lymphocytes and macrophages in the normal breast. Virchows Arch A Pathol Anat Histopathol. 1985; 407:369–378.
4. Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology. 2007; 245:692–702.
5. Lyou CY, Yang SK, Choe DH, Lee BH, Kim KH. Mammographic and sonographic findings of primary breast lymphoma. Clin Imaging. 2007; 31:234–238.
6. Surov A, Holzhausen HJ, Wienke A, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. Br J Radiol. 2012; 85:e195–e205.
7. Demirkazik FB. MR imaging features of breast lymphoma. Eur J Radiol. 2002; 42:62–64.
8. Mussurakis S, Carleton PJ, Turnbull LW. MR imaging of primary non-Hodgkin's breast lymphoma. A case report. Acta Radiol. 1997; 38:104–107.
9. Darnell A, Gallardo X, Sentis M, Castañer E, Fernandez E, Villajos M. Primary lymphoma of the breast: MR imaging features. A case report. Magn Reson Imaging. 1999; 17:479–482.
10. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med. 2008; 26:222–226.
11. Ei Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010; 256:64–73.
12. Matsubayashi RN, Inoue Y, Okamura S, Momosaki S, Nakazono T, Muranaka T. MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review. Jpn J Radiol. 2013; 31:668–676.
13. Mountford C, Ramadan S, Stanwell P, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed. 2009; 22:54–64.
14. Begley JK, Redpath TW, Bolan PJ, Gilbert FJ. In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Res. 2012; 14:207.
15. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology. 2006; 239:686–692.
16. Demirkan B, Balci P, Ozcan MA, et al. Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examination. Breast. 2005; 14:169–174.